BRONTE CAPITAL MANAGEMENT PTY LTD. Regeneron Pharmaceuticals, Inc. Transaction History

BRONTE CAPITAL MANAGEMENT PTY LTD. portfolio value:

$101.38M
portfolio value

BRONTE CAPITAL MANAGEMENT PTY LTD. quarter portfolio value change:

+16.53%
quarter

Regeneron Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -1.35% -2.01K shares 13.19M $688.87 147.17K
Q2 2022 share Increase +7.32% 10.17K shares -8.90M $591.13 149.18K
Q1 2022 share Increase +6.56% 8.55K shares 14.70M $698.42 139.01K
Q4 2021 share Increase +5.02% 6.23K shares 7.21M $642.51 130.46K
Q3 2021 share Increase +5.75% 6.75K shares 9.56M $605.18 124.22K
Q2 2021 share Increase +97.80% 58.08K shares 37.51M $558.54 117.46K
Q1 2021 share Increase +211.69% 40.33K shares 18.89M $473.14 59.38K
Q4 2020 share Increase 0.00% 19.05K shares 9.20M $483.11 19.05K